Your browser doesn't support javascript.
loading
Changes in BAI1 and nestin expression are prognostic indicators for survival and metastases in breast cancer and provide opportunities for dual targeted therapies.
Meisen, Walter Hans; Dubin, Samuel; Sizemore, Steven T; Mathsyaraja, Haritha; Thies, Katie; Lehman, Norman L; Boyer, Peter; Jaime-Ramirez, Alena Cristina; Elder, J Bradley; Powell, Kimerly; Chakravarti, Arnab; Ostrowski, Michael C; Kaur, Balveen.
Afiliação
  • Meisen WH; Department of Neurological Surgery, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio.
  • Dubin S; Department of Neurological Surgery, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio.
  • Sizemore ST; Department of Radiation Oncology, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio.
  • Mathsyaraja H; Department of Molecular and Cellular Biochemistry, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio.
  • Thies K; Department of Molecular and Cellular Biochemistry, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio.
  • Lehman NL; Department of Neurological Surgery, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio. Department of Pathology, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio.
  • Boyer P; Small Animal Imaging Shared Resources, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio. Department of Biomedical Informatics, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio.
  • Jaime-Ramirez AC; Department of Neurological Surgery, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio.
  • Elder JB; Department of Neurological Surgery, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio.
  • Powell K; Small Animal Imaging Shared Resources, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio. Department of Biomedical Informatics, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio.
  • Chakravarti A; Department of Radiation Oncology, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio.
  • Ostrowski MC; Department of Molecular and Cellular Biochemistry, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio.
  • Kaur B; Department of Neurological Surgery, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio. Department of Radiation Oncology, James Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio. balveen.kaur@osumc.edu.
Mol Cancer Ther ; 14(1): 307-14, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25376607

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Proteínas Angiogênicas / Vírus Oncolíticos / Nestina Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2015 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Proteínas Angiogênicas / Vírus Oncolíticos / Nestina Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2015 Tipo de documento: Article País de publicação: Estados Unidos